Literature DB >> 30407920

Long-term complications in patients with chronic hypoparathyroidism: a cross-sectional study.

K David1, C Moyson1, D Vanderschueren1, B Decallonne1.   

Abstract

Objective Chronic hypoparathyroidism and its treatment may lead to symptoms and complications affecting quality of life. We determined complications in chronic hypoparathyroid patients. Design Retrospective cross-sectional study of patients with chronic hypoparathyroidism treated with active vitamin D supplements in a tertiary care centre during the year 2015. Primary outcome parameters were history of kidney stones and seizures and presence of renal and cerebral calcifications on imaging. Secondary outcome parameters were current symptoms of paraesthesia/cramps, hospitalization due to hyper/hypocalcaemia and hypercalciuria. Subjects One hundred and seventy patients were included - 143 (84%) with post-surgical hypoparathyroidism (PSHP), 16 (9%) with non-surgical hypoparathyroidism (NSHP) and 11 (7%) with pseudo-hypoparathyroidism (PHP). Results History of kidney stones and seizures was present in 15 and 9% of patients, respectively. Renal and cerebral imaging was performed in 51 and 26% of the patients, with 22 and 25% of these patients having renal and cerebral calcifications respectively. Both history of seizures and cerebral calcifications were significantly more in NSHP and PHP than in PSHP patients. No association was observed between seizures and cerebral calcifications. Cramps/paraesthesia were present in 16%, and hospitalization related to hypocalcaemia was reported in 5% of the patients. Calciuria was screened in 47% at the time of consultation, and in 76% of the patients during the past 5 years. In 36% of these patients, calciuria was increased. Conclusions Patients with chronic hypoparathyroidism frequently develop ectopic calcifications. Non-surgical patients suffer more from seizures and cerebral calcifications than patients that developed hypoparathyroidism post surgery. There is a need for increased screening of long-term complications, according to the guidelines.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30407920     DOI: 10.1530/EJE-18-0580

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  10 in total

1.  Effect of postsurgical chronic hypoparathyroidism on morbidity and mortality: a systematic review and meta-analysis.

Authors:  Deena Hadedeya; Joshua Kay; Abdallah Attia; Mahmoud Omar; Mahmoud Shalaby; Mohanad R Youssef; Mohamed Shama; Eman Toraih; Emad Kandil
Journal:  Gland Surg       Date:  2021-10

2.  Renal complications and quality of life in postsurgical hypoparathyroidism: a case-control study.

Authors:  L Mazoni; A Matrone; M Apicella; F Saponaro; S Borsari; E Pardi; B Cosci; I Biagioni; P Rossi; F Pacciardi; A Scionti; R Elisei; C Marcocci; F Cetani
Journal:  J Endocrinol Invest       Date:  2021-10-12       Impact factor: 4.256

Review 3.  Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.

Authors:  Damien Bouriez; Caroline Gronnier; Magalie Haissaguerre; Antoine Tabarin; Haythem Najah
Journal:  World J Surg       Date:  2022-06-29       Impact factor: 3.282

4.  Lower Leg Arterial Calcifications Assessed by High-Resolution Peripheral Quantitative Computed Tomography in Hypoparathyroid and Pseudohypoparathyroid Patients.

Authors:  Catharina Vind Nielsen; Line Underbjerg; Diana Grove-Laugesen; Tanja Sikjaer; Lars Rejnmark
Journal:  Calcif Tissue Int       Date:  2021-02-12       Impact factor: 4.333

5.  Parathyroid hormone of ≥1.6 pmol/L at 6 months is associated with recovery in 'long-term' post-surgical hypoparathyroidism.

Authors:  Muhammad Fahad Arshad; Amardass Dhami; Gillian Quarrell; Saba Prakash Balasubramanian
Journal:  Eur Thyroid J       Date:  2022-05-11

6.  Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.

Authors:  Michael Mannstadt; Bart L Clarke; John P Bilezikian; Henry Bone; Douglas Denham; Michael A Levine; Munro Peacock; Jeffrey Rothman; Dolores M Shoback; Mark L Warren; Nelson B Watts; Hak-Myung Lee; Nicole Sherry; Tamara J Vokes
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

7.  Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey.

Authors:  Heide Siggelkow; Bart L Clarke; John Germak; Claudio Marelli; Kristina Chen; Helen Dahl-Hansen; Elizabeth Glenister; Nawal Bent-Ennakhil; Davneet Judge; Katie Mycock; Jens Bollerslev
Journal:  Clin Endocrinol (Oxf)       Date:  2019-12-11       Impact factor: 3.478

8.  Prevalence of basal ganglia and carotid artery calcifications in patients with permanent hypoparathyroidism after total thyroidectomy.

Authors:  Leyre Lorente-Poch; Sílvia Rifà-Terricabras; Juan José Sancho; Danilo Torselli-Valladares; Sofia González-Ortiz; Antonio Sitges-Serra
Journal:  Endocr Connect       Date:  2020-10       Impact factor: 3.335

9.  Risk of Chronic Kidney Disease and Estimated Glomerular Filtration Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study.

Authors:  Elvira O Gosmanova; Kristina Chen; Lars Rejnmark; Fan Mu; Elyse Swallow; Allison Briggs; Olulade Ayodele; Nicole Sherry; Markus Ketteler
Journal:  Adv Ther       Date:  2021-03-09       Impact factor: 3.845

10.  Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: a Belgium and the Netherlands survey.

Authors:  N A T Hamdy; B Decallonne; P Evenepoel; D Gruson; L van Vlokhoven-Verhaegh
Journal:  J Endocrinol Invest       Date:  2020-10-30       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.